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Noroviruses are the major cause of foodborne outbreaks of acute gastroenteritis,
which are often linked to raw oyster consumption. Previous studies have suggested
histo-blood group antigens (HBGA)-like structures in the oyster tissues as ligands
for norovirus binding and persistence. To better understand how oysters function as
vectors for the most common human noroviruses, we first tested the ability of the
norovirus strains GI.1 West Chester, the pandemic GII.4 Sydney, and the epidemic
GII.17 Kawasaki308 strains to interact with oyster tissues. Secondly, we explored how
the HBGA preferences of these strains can affect their persistence in oyster tissues.
We found limited HBGA expression in oyster tissues. HBGAs of A and H type 1 were
present in the digestive tissues and palps of the Pacific oyster Crassostrea gigas, while
the gills and mantle lacked any HBGA structures. By using Virus-like particles (VLPs),
which are antigenically and morphologically similar to native virions, we were able to
demonstrate that VLPs of GI.1 West Chester norovirus reacted with the digestive tissues
and palps. Despite of the lack of HBGA expression in mantle, dominant GII.4 Sydney
strain readily bound to all the oyster tissues, including the digestive tissues, gills, palps,
and mantle. In contrast, no binding of the epidemic GII.17 Kawasaki308 VLPs to any
of the investigated oyster tissues was observed. In synthetic HBGA and saliva-binding
assays, GI.1 reacted with A type, H type, and Leb (Lewis b) HBGAs. GII.4 Sydney VLPs
showed a broad binding pattern and interacted with various HBGA types. Compared to
GI.1 and GII.4 VLPs, the GII.17 Kawasaki308 VLPs only weakly associated with long-
chain saccharides containing A type, B type, H type, and Leb blood group epitopes. Our
findings indicate that GI.1 and GII.4 noroviruses are likely to be concentrated in oysters,
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by binding to HBGA-like glycans, and therefore potentially leading to increased long
term transmission. In regards to the GII.17 Kawasaki308 strain, we suggest that oysters
can only function as short term transmission vector in periods of high environmental
virus concentrations.
Keywords: norovirus, histo-blood group antigens (HBGA), oyster, norovirus outbreak, food pathogens, norovirus
transmission, food safety
INTRODUCTION
Noroviruses are non-enveloped single stranded RNA viruses
of the Caliciviridae family. According to the most recent
classification, there are seven genogroups (GI- GVII) in the
norovirus genus (Vinjé, 2015). Noroviruses of the GI and GII
genogroups have been detected in humans. However, most
norovirus infections over the past decade have been caused by
genogroup II genotype 4 (GII.4) noroviruses. The GII.4 variants
are responsible for six pandemics and for the majority of sporadic
outbreaks worldwide (Noel et al., 1999; Widdowson et al., 2004;
Bull et al., 2006; Eden et al., 2010, 2014; Yen et al., 2011). Recently
a novel GII.17 strain has emerged in Asia, causing an alarming
number of infections and gradually replacing GII.4 strains (Chan
et al., 2015a; Zhang et al., 2015; Koromyslova et al., 2017).
Norovirus are highly infectious, with as few as ten particles
being able to cause disease (Teunis et al., 2008). Viral
transmission occurs either via direct person-to-person contact
or indirectly through contaminated water or food. In fact,
noroviruses are considered one of the most common cause of
foodborne infections associated with gastroenteritis outbreaks
(Atmar and Estes, 2006; Moore et al., 2015; de Graaf et al., 2016).
Many food-related disease outbreaks of acute gastroenteritis
caused by noroviruses are associated with oyster consumption.
Oysters are filter-feeding epibenthic bivalves, which filter up to 19
liters of water per hour and gram bodyweight (Jørgensen, 1996),
and have been found to accumulate different pathogens from sea
water. Oysters become contaminated with norovirus by exposure
to discharging municipal water supply (Lees, 2000) and their raw
consumption often results in outbreaks of acute gastroenteritis
(Ang, 1998; Doré et al., 2010; Westrell et al., 2010).
It has been suggested that noroviruses are bound by oyster
tissues through specific carbohydrate-mediated interactions,
which involve the norovirus capsid protein (viral protein 1,
VP1) and human-like histo-blood group antigens (HBGA).
Human HBGAs are carbohydrate epitopes at the terminal end
of O-glycans on glycoproteins and of glycolipids on the surface
of red blood cells, the mucosal epithelium of the gastrointestinal,
and the respiratory and the genitourinary tracts. Specific HBGAs,
similar to blood group A type and H type, have also been
identified in the digestive tracts of different oyster species (Tian
et al., 2007; Ma et al., 2017).
The human noroviruses interact with HBGAs and oyster
tissues in a strain-dependent manner. The GI.1 Norwalk
noroviruses exhibit strong preferences toward A-type and H-type
glycans and bind to the oyster digestive tissues (Le Guyader
et al., 2006; Tian et al., 2006, 2007; Maalouf et al., 2010,
2011). Importantly, the GI.1 Norwalk VLP binding correlates
with the expression of A-type HBGAs in the oyster digestive
tract (Tian et al., 2007). Lastly, both GI.1 Norwalk VLPs and
GI.1 virions from a stool sample were shown to be efficiently
bioaccumulated by Crassostrea gigas (Maalouf et al., 2010, 2011).
In contrast, the GII.4 Houston norovirus readily interacts with
the digestive tissues, gills, and mantle tissue extracts through
sialylated carbohydrates. Despite this, only low levels of GII.4
Houston norovirus VLPs were bioaccumulated by Crassostrea
gigas, which was suggested to be due to an unknown degradation
mechanism (Maalouf et al., 2011).
The dominant GII.4 Sydney 2012 noroviruses are most
abundant among GII strains detected in samples from the oyster-
related outbreaks (Yu et al., 2015). Likewise, recent reports have
found epidemic GII.17 noroviruses in oysters collected from
the coasts of Italy, Japan, and Korea (Shin et al., 2013; Pu
et al., 2016; La Rosa et al., 2017). Moreover, Rasmussen et al.
directly linked a series of acute gastroenteritis infections with the
consumption of GII.17-contaminated oysters (Rasmussen et al.,
2016). In this work, we aimed at gaining a better understanding of
how GII.4 Sydney and GII.17 Kawasaki308 strains are potentially
transmitted to humans via oysters. To this end, we expressed the
human norovirus capsid protein in insect cells. The expression
resulted in the formation of VLPs, which are antigenically and
morphologically analogous to native virions (Harrington et al.,
2004; Hansman et al., 2006; Bok et al., 2009; Lindesmith et al.,
2011, 2012, 2013; Ajami et al., 2012). Next, we measured oyster-
tissue specificity of the GII.4 Sydney and GII.17 Kawasaki308
norovirus VLPs. We explored how binding preferences of these
strains toward specific HBGAs can affect their persistence in
oyster tissues. We compared the behavior of GII.4 and GII.17
noroviruses with the GI.1 norovirus, which is commonly found
in oysters (Yu et al., 2015). The combination of these approaches
will thus allow us to make specific predictions of the expected
epidemiology of these norovirus strains.
MATERIALS AND METHODS
Reagents
We examined VLP binding to multivalent-HBGAs conjugates
purchased from GlycoTech (Maryland, United States). They
included Ley-PAA-biotin (01-043), Leb-PAA-biotin (01-042), H
type1(tri)-PAA-biotin (01-037), Lex-PAA-biotin (01-036), Lea-
PAA-biotin (01-035), H type 2 (tri)-PAA-biotin (01-034), Blood
type A (tri)-PAA-biotin (01-032), Blood type B (tri)-PAA-biotin
(01-033). The following monoclonal antibodies (MAbs) were
purchased for the HBGA phenotyping: A type antibodies (clone
Birma-1, Medtro GmbH), B type antibodies (clone LB-2, Medtro
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GmbH), H type 1 antibodies (clone 17-206, Invitrogen), Lewis
a antibody (clone 7LE, ThermoFisher), Lewis b antibody (clone
25LE, Abnova), Lewis x antibody (clone 73–30, TCI chemicals),
Lewis y antibody (clone H18A, TCI chemicals). Porcine gastric
mucin type III (PGM) was purchased from Sigma-Aldrich
(M2378). Goat α-mice IgG HRP conjugated antibodies were
purchased from ThermoFisher (62-6520).
Norovirus Virus-Like Particles (VLPs)
The GI.1 West Chester (2001, AY502016), GII.4 Sydney
(X459908), GII.17 Kawasaki308 (2015, LC037415) VLPs were
produced in Spodoptera frugiperda (Sf9) cells using baculovirus
expression system as described previously (Koromyslova et al.,
2017). In short, the recombinant VP1 bacmids were transfected
into the Sf9 cells using Effectene (Qiagen). After 5 days of
incubations at 27◦C the cells were harvested, centrifuged, and the
supernatant containing baculovirus was used to infect high five
(H5) insect cells. The H5 cells were incubated at 27◦C for 6 days.
At 6 days post infection, the supernatant containing secreted
VLPs was collected. The VLPs were concentrated by ultra-
centrifugation at 35000 rpm (SW55 Ti rotor, Beckman Coulter)
for 2 h at 4◦C and purified by the CsCl equilibrium gradient
ultracentrifugation at 35000 rpm (SW55 Ti rotor, Beckman
Coulter) for 18 h at 4◦C. The morphology of the VLPs was
examined by electron microscopy.
Oyster and Saliva Samples
All experiments were performed with the Pacific oysters
Crassostrea gigas. The oysters were collected from an
uncontaminated area on Sylt, North Sea, Germany, 54.937962◦
N, 8.313825◦ E, and shipped the same day (within 24 h) on ice
to the laboratory in Mannheim. Upon arrival, the oysters were
immediately dissected and the digestive tissues, mantles, gills,
and pulps were collected from five to six different oysters. The
tissues were homogenized in phosphate-buffered saline (PBS)
pH 7.4, boiled for 10 min at 95◦C and centrifuged at 8000 rpm
for 5 min (Mikro 200, Hettich). The supernatants were collected
and used for ELISA experiments after the protein concentration
was measured with the Bio-Rad protein assay kit. The tissue
homogenate was tested for the presence of preexisting GI or
GII norovirus contamination by a GeneXpert commercial assay
according to the manufacturer’s instructions (Cepheid Inc.,
Sunnyvale, CA, United States) (data not shown). The oysters
which were artificially exposed to norovirus-containing stool
samples were used as a positive control.
Saliva samples collected from 17 healthy adult persons were
boiled for 10 min at 95◦C and centrifuged at 8000 rpm for 5 min
(Mikro 200, Hettich). Approval was obtained from the ethics
committee of the Medical Faculty of Mannheim, Heidelberg
University, #2017-528N-MA.
Detection of VLPs Binding to Oyster
Tissues, Saliva Samples, and Synthetic
HBGAs
The binding of the GI.1 West Chester, the pandemic GII.4
Sydney, and the epidemic GII.17 Kawasaki308 norovirus VLPs
to oyster tissues was measured in triplicate for each oyster
(Koromyslova et al., 2017). Briefly, NuncMaxisorp plates were
covered with the digestive tract, mantle, gill, and pulp tissue
extracts at a concertation of 40 µg/ml for 1 h at 37◦C. The plates
were washed three times with PBS-Tween20 0.1% (PBS-T) and
blocked with 5% bovine serum albumin (BSA) for 1 h at 37◦C.
Subsequently, a serial dilution of VLPs (0–20 µg/mml, PBS) was
applied to the plate for 1 h at 37◦C. Plates were washed and
incubated for 1 h at 37◦C with either α-VLP-His6 nanobodies
(Nb85) for GI.1 VLPs, α-rabbit-polyclonal antibodies for GII.4
VLPs, or α-VLP-biotinylated nanobodies (Nb26) for GII.17 VLPs
(Koromyslova and Hansman, 2017). After washing the plate,
the secondary antibodies (horseradish peroxidase conjugated
with α-His6-IgG, α-rabbit-IgG or streptavidin) were added.
Finally, the washed plates were developed for 30 min at room
temperature with o-phenylenediamine (OPD) and H2O2. The
reaction was stopped after 30 min and absorbance was measured
at 490 nm on a Tecan infinite M200 Multiwell reader (Tecan,
Switzerland). Negative controls included a VLP-negative control
and primary antibody-negative controls. PGM and secretor saliva
samples, described below in the results, were used as positive
controls.
For the synthetic HBGA assays, carbohydrate-polyacrylamide
- biotin (HBGAx-PAA-biotin) conjugates were diluted to a final
concentration of 20 µg/ml in PBS and applied on streptavidin-
coated plates overnight at 4◦C. The plates were blocked and
a serial dilution of VLPs (0–20 µg/mml, PBS) was applied.
The concentration of bound VLPs was detected as described
above.
For the saliva binding assay, 100 µl of the 1:50 diluted saliva
samples (each sample was measured in triplicate) was added to
carbohydrate buffer pH 9.4, and were incubated overnight at
4◦C, then washed and blocked. The plates were incubated with
10 µg/ml VLPs in PBS and the concentration of bound VLPs was
detected as described above.
Detection of HBGA Present in Saliva and
Oyster Tissues
The HBGAs phenotypes expressed in the oyster tissues and saliva
samples were determined using MAbs as previously described
(Tian et al., 2007). Each incubation step was followed by a
washing step (3X PBS-T). The oyster tissues extracts were coated
on NuncMaxisorp plates overnight at 4◦C. Plates were blocked
with 5% BSA in PBS-T for 1 h at 37◦C. 100 µl of 1:400 α-A
type MAbs, 1:100 α-B type MAbs, 1:250 α-H type 1MAbs, 1:50
α-Lewis a type MAbs, 1:1800 α-Lewis b type MAbs, 1:800 α-Lewis
x type MAbs, and 1:3200 α-Lewis y type MAbs were incubated
for 1 h at 37◦C. Goat α-mice IgG HRP conjugated Abs were used
in the 1:800 – 1:3200 dilution range for 1 h at 37◦C. The signal
was developed with the OPD/H2O2 mixture for 30 min and the
intesity was measured on the Tecan reader.
Statistical Analysis
Means were compared by using the Student t-test, and a
P-value of below 0.05 was considered as statistically significant
(GraphPad Prisma Software, La Jolla, CA, United States).
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FIGURE 1 | The binding of (A) GI.1West Chester VLPs, (B) GII.4 Sydney
VLPs, (C) and GII.17 Kawasaki308 VLPs to digestive tissues, gills, mantle,
and palp tissue extracts. All data are given as mean from five-six oysters
measured separately ± standard deviations (SD), Asterisks indicate
statistically significant differences (comparison to PBS control, p < 0.05).
RESULTS
GI.1, GII.4, and GII.17 VLP Binding to
Oyster Tissues
GI.1 West Chester VLPs bound to the digestive tissues were easily
detected even at the lowest concentration of 1.25 µg/ml, while no
binding to mantle and gills was observed (Figure 1A). In contrast
to previous studies (Maalouf et al., 2011) which used a different
GI.1 strain, GI.1 West Chester VLPs also bound to palp tissue
extracts. However, the binding was expected since A type HBGAs
are present in palps (Figure 3A). This A type HBGA-dependency
was indirectly confirmed by high standard deviations, which
match the different levels of A type HBGA expression in the
various oyster samples (Supplementary Figure S1).
Similar to the less prevalent GII.4 variant (Maalouf et al.,
2011), the dominant GII.4 Sydney VLPs showed a strong
binding efficiency to all tissues tested, even at the lowest VLP
concentration (Figure 1B).
FIGURE 2 | Expression of HBGA-like molecules in digestive tissues, gills,
mantle, and palp tissue extracts of Pacific oyster. Data presented as mean
(n = 5) ± SD.
Surprisingly, no binding of the epidemic GII.17 Kawasaki308
VLPs to any of the oyster tissues was observed (Figure 1C).
Although we obtained signals in the PGM coated wells
(i.e., positive controls), all of the GII.17 VLPs assayed at
a concentration of 20–1.25 µg/ml produced readings below
the detection limit. The assay was repeated several times in
parallel with the GI.1 and GII.4 binding experiments using
the same tissue extracts. Additionally, testing higher VLP
concentrations of 80 µg/ml, different coating procedures with
higher concentrations of tissue extracts, and longer incubation
times had no effect on the GII.17 VLP binding (Supplementary
Figure S2). To exclude any seasonal factors which could
have contributed to the GII.17 VLP binding, the assays were
also conducted with oysters collected in December and June.
However, these binding assays also resulted in qualitatively
similar negative results (Supplementary Figure S3).
Expression of HBGA in Oyster Tissues
The HBGA phenotypes present in oyster tissues were examined
by eight MAbs which recognize A type, B type, H type 1
and Lea,b,x,y HBGA epitopes. The binding cut-off was set at
OD490 = 0.18, which was three times the value of the PBS control.
Only A type and H type 1 carbohydrates were found to be present
in the tissues (Figure 2). The A type carbohydrates were detected
in the digestive tissues (OD490 = 0.28) and palps (OD490 = 0.27).
Likewise, H type 1 HBGAs were present in the digestive tissues
(OD490 = 0.31), gills (OD490 = 0.26), and palps (OD490 = 0.27).
None of the other tested HBGAs (B type and Lea,b,x,y) were
detected in the oyster tissue extracts.
VLP Binding to Saliva Samples
To evaluate HBGA binding preferences of the norovirus VLPs
in the human host, we performed saliva binding assays using a
panel of saliva samples from 17 healthy adult individuals (subject
A–Q). Prior to the VLP binding assay, the saliva samples were
tested for the ABO, Lewis, and secretor phenotypes using the
MAbs. Saliva containing Leb and Ley antigens were defined as
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FIGURE 3 | (A) Expression of ABH and Lewis antigens in saliva samples
(A–Q). (B) The binding of GI.1 West Chester VLPs, GII.4 Sydney VLPs, and
GII.17 Kawasaki308 VLPs to saliva samples (A–Q). Triplicate assay of 1:50
saliva dilution per well.
secretor positive probes, while the absence of the A, B, H, Ley,
Leb antigens suggested a non-secretor status. Overall, thirteen
samples were secretor positive and four samples were from non-
secretors (subjects B, E, K, P) (Figure 3).
The GI.1 West Chester VLPs bound strongly to the saliva
probes J and L (OD490 > 1.0), containing A/H1/Lea,b,x,y and
A/Lea,b,x,y type glycans, respectively (Figure 3A). The moderate
binding was also observed for the subjects A (A/H1/Lea,b,x,y), C
(H1/Lea,b,x,y), D (A/Lea,b,x,y), G (A/B/Lea,b,x,y), I (A/Lea,b,x,y),
O (A/Lea,b,x,y). Weak and no GI.1 VLP binding was observed
for saliva samples B, P, E, F, K, which lack A type and H type
1 carbohydrates. Overall, the GI.1 West Chester VLP binding
profile matched well-established preferences of GI.1 Norwalk
VLPs toward H1, Leb and A type antigens (Harrington et al.,
2002; Hutson et al., 2002; Huang et al., 2003; Shirato et al., 2008).
GII.4 VLPs bound to all secretor positive samples, and with an
OD490 in the 0.4–0.6 range (Figure 3B). Only weak or no binding
was observed for the non-secretor saliva samples (B, E, K, P).
The GII.17 VLPs demonstrated the highest signal, with an
OD490 > 0.67, for subjects G (A/B/Lea,b,x,y), J (A/Lea,b,x,y),
L(A/B/Lea,b,x,y), N (A/B/Lea,b,x,y) (Figure 3B). Moderate
binding of OD490 = 0.53–0.56 was observed for the subjects I
(A/Lea,b,x,y) and Q (B/Lea,b,x,y). In contrast, subjects B, K, P, E
FIGURE 4 | Binding patterns of 20–2.5 µg/ml (A) GI.1West Chester VLPs,
(B) GII.4 Sydney VLPs to PAA-conjugated HBGAs synthetic HBGAs. Triplicate
measurements for each VLP concentrations. Asterisks indicate statically
significant differences (comparison to PBS control, p < 0.05).
containing predominantly the Lea and Leb antigens displayed
absorbance readings that were below or just above the cut-off
limit (OD490 < 0.2).
With some exceptions, the saliva binding pattern of GII.17
VLPs closely resembled the binding patterns of GI.1 VLPs
(Figure 3B). However, in contrast to GI.1 VLPs, GII.17 VLPs
demonstrated a stronger binding for the subjects F, N, Q.
These subjects were B positive and A type negative phenotypes,
suggesting that GII.17 VLPs recognize H1, Leb, A type, but also B
type antigens.
VLP Binding to Synthetic HBGAs
Saliva is a complex biofluid containing a mixture of HBGA
glycans. To define specificities of GI.1 West Chester, GII.4
Sydney, and the GII.17 Kawasaki308 norovirus VLPs toward
individual HBGA types, we further performed a synthetic
oligosaccharide-based assay using polyacrylamide-conjugated
multivalent HBGAs. As shown in Figure 4A, GI.1 VLPs
recognized H type 1 trisaccharides, which was dose-dependent.
A higher amounts of GII.4 VLPs bound to B type and lower to
Ley and Leb types (Figure 4B). Interestingly, GII.17 VLPs did
not bind to tested PAA-conjugated HBGAs, under the studied
conditions.
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TABLE 1 | Summary of the HBGA binding preferences combined from saliva and
synthetic HBGA assays.
A type B type H type 1 Lea Leb Lex Ley
GI.1 West
Chester
+ − + − + − −
GII.4
Sydney




+ + + − + − −
DISCUSSION
Human noroviruses are genetically and antigenically diverse
(Hansman, 2006), with a majority of the human norovirus
infections being caused by the GII strains. According to the
Noronet report April 2014, approoximately 91% of all norovirus
sequences collected worldwide belong to the genogroup GII. 74%
of these norovirus sequences were GII.4 variants. GI noroviruses
compromised only approximately 9% of all outbreaks. Most of
the norovirus genotypes which infect humans have also been
found in oyster-related outbreak samples. However, the GI
and GII proportions are significantly different in oyster-related
outbreaks than in non-oyster related outbreaks. In oyster-related
outbreaks, only 66% of all norovirus sequences found belonged
to the GII strains (Noronet, 2014)1. Moreover, the dominant
GII.4 strains only accounted for 30% of the GII sequences
reported. This shift could have been driven by the more frequent
occurrence of GI strains in coastal waters. However, influent
and eﬄuent waters still contain higher concentrations of GII
noroviruses (Flannery et al., 2012), indicating that oysters are
also exposed to higher GII concentrations. Consequently, GI
noroviruses must be enriched in oyster tissues, where selection
and persistence is dependent on specific molecular interactions
between the virus and the oyster. Such specific viral enrichment
might be mechanistically similar to HBGA-norovirus binding in
humans (Tian et al., 2006, 2007; Maalouf et al., 2011).
Histo-blood group antigens located on epithelial cells of the
human gastrointestinal tract are receptors or co-receptors for
human noroviruses. Certain HBGA types are also expressed in
oyster tissues. Tian et al. (2007) detected A type-like and H type-
like HBGAs in the gastrointestinal tissues of Crassostrea virginica,
Crassostrea gigas, and Crassostrea sikamea. Similarly, in our study
we were able to demonstrate that both A type and H type 1 were
present in the digestive tissues of Crassostrea gigas. Additionally,
we demonstrated that the palps also contained these HBGAs,
while gills and mantle showed undetectable levels of any HBGA
types.
Norovirus interaction with HBGAs has been shown to occur
via the protruding (P) domain of the major capsid VP1 protein
(Cao et al., 2007; Choi et al., 2008; Hansman et al., 2011).




norovirus strains define their binding preferences toward specific
HBGA types. A summary of the HBGA binding preferences
of the GI.1 West Chester, the pandemic GII.4 Sydney, and the
epidemic GII.17 Kawasaki308 norovirus VLPs is presented in
Table 1. We observed that GI.1 VLPs used in this study readily
reacted with A type, AB type, and H type, but not with B type
saliva. Moreover, these GI.1 VLPs also bound to synthetic PAA
conjugated H type 1 HBGAs. This matches previous results of
another GI.1 strain, which demonstrated that the prototype GI.1
Norwalk noroviruses preferentially recognize A-type and H-type
1 HBGAs, and might also bind Leb antigens (Harrington et al.,
2002; Hutson et al., 2002; Huang et al., 2003; Shirato et al.,
2008). As was expected from its HBGA binding capabilities, we
found that GI.1 VLPs reacted with digestive tissues and palps
of Crassostrea gigas, which predominantly contained A type and
H type HBGAs. This further supports previous observations
obtained from oysters (Maalouf et al., 2011).
The most prevalent GII.4 noroviruses seem to possess a broad
and long-standing HBGA binding profile. Evolutionary studies
revealed a highly conserved HBGA binding site in the GII.4
norovirus strains isolated throughout the 1974–2012 period (Bok
et al., 2009). With the exception of the structural studies (Singh
et al., 2015; Morozov et al., 2018), the HBGA binding preferences
of the most virulent GII.4 Sydney strain were largely unexplored.
Here, we demonstrated that the GII.4 Sydney VLPs interacted
equally well to secretor and non-secretor saliva samples. Non-
secretors do not express H1 and Lewis-b epitopes, and hence the
observed binding could be due to Lewis-y or H2 interference.
In the synthetic HBGAs assays, the GII.4 Sydney VLPs reacted
with B type trisaccharide-PAA, Leb type tetrasaccharide-PAA, Ley
type tetrasaccharide-PAA conjugates. However, the latter results
have to be treated with caution, due to that fact that the short
carbohydrate chains are attached to a polymer linker, and are
therefore less accessible for the bulky VLP structure. Our parallel
work, using carbohydrate mixtures from breast milk (human
milk oligosaccharides, HMOs), revealed the specificity of GII.4
Sydney VLPs toward longer saccharides containing 4–15 sugar
units and the terminal blood group H type 1 or Lewis-b epitopes
(Hanisch et al., 2018). Together these results suggest that GII.4
Sydney VLPs can recognize a broad spectrum of carbohydrates,
including Leb, H type 1, Ley, and B type blood group antigens,
although the affinities to each specific HBGA type remain to
be elucidated. In this study, GII.4 Sydney bound well to all the
investigated oyster tissues. In case of the digestive tissues this can
be explained by recognition of the H type 1 HBGAs, while the
binding to the mantle and gill tissues can most likely be explained
by the presence of non-HBGA carbohydrates, as it was previously
observed for GII.4 Houston VLPs (Maalouf et al., 2011).
Enhanced HBGA binding capabilities have been put forward
as a factor to explain the rapid emergence of the GII.17
strains (Chan et al., 2015b). However, in our synthetic HBGA
assay, only low concentrations of GII.17 Kawasaki308 VLPs
associated with the sugars. As previously mentioned, this
may have been due to steric effects, the affinity of GII.17
Kawasaki308 to short-chain HBGA-containing PAAs used on
our plates was likely lower compared to GII.4, and GI.1
strains. GII.17 Kawasaki308 VLPs could nevertheless interact
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with longer saccharides and with glycoproteins present in saliva
of secretor-positive individuals. Its binding patterns closely
resembled those of GI.1 VLPs, but showed additional signals in
B type subjects, which supports its enhanced binding capabilities.
We observed no binding of GII.17 Kawasaki308 to the oyster
tissues extracts, therefore we assumed that GII.17 Kawasaki308
exhibited low affinity interactions with endogenous blood group
active oligosaccharides (A type, B type, H type, Leb blood group
epitopes), and,thus, just weakly attach to the HBGA epitopes
expressed in the digestive tissues of pacific oysters.
Considering these binding assay results it is surprising that
oysters can be contaminated with GII.17 noroviruses (Shin et al.,
2013; Pu et al., 2016; Rasmussen et al., 2016; La Rosa et al., 2017).
One explanation could be that the epidemic GII.17 noroviruses
do not actively accumulate through tissue binding in oysters
and only use oysters as a short term transmission vector via
passive accumulation during filter feeding. This might also apply
to other norovirus genotypes detected in oyster related outbreaks.
Oyster only express a limited array of HBGA types that, in
some cases, cannot be recognized by every norovirus strain. It
is therefore suggested, that many noroviruses can interact with
tissues only non-specifically, while other noroviruses, i.e., GI.1,
can be efficiently accumulated within oysters. Such binding-
dependent accumulation could explain the shift toward the
increased presence of GI genotypes in oysters (Yu et al., 2015).
Alternatively, other unidentified proteins or, as it was shown
for the GII.4 Houston strain, non-HBGA glycans could act
as selective ligands for the norovirus accumulations in oysters
(Maalouf et al., 2010). These molecules or a larger variety of
HBGAs could also be provided by the diverse microbiome of the
oyster digestive tract (Lokmer et al., 2016) that might therefore,
serve as a substrate for norovirus recognition and accumulation
(Miura et al., 2013; Li et al., 2015).
From the combination of binding assays applied in
this study, we conclude that the pandemic GII.4 Sydney
norovirus strains are likely to employ H type 1-mediated
interactions to accumulate within oysters, which could
potentially lead to long-term transmission. The epidemic
GII.17 noroviruses, on the other hand are likely to have
low persistence in oysters and transmission is suggested to
be short-term, when high environmental concentration of
these viruses is found. Understanding these strain specific
characteristics of persistence will allow the prediction of
norovirus epidemiology, which is vital for the development of
control measures.
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